Association of Fcγ Receptor Polymorphisms with Adult Onset Still’s Disease in Korea

Objective. Fcγreceptors (FcγR) have important functions in the regulation of immune response and clearance of immune complex. High levels of immunoglobulins have been observed in patients with the active stage of adult onset Still’s disease (AOSD), and high-dose intravenous immunoglobulin treatment has decreased the disease activity of AOSD. We investigated polymorphisms of FcγR as genetic factors influencing susceptibility or disease course of AOSD in Korea. Methods. We genotyped the FcγRIIA H/R131, IIIA F/V176, and IIIB NA1/NA2 loci in 98 patients with AOSD and 151 healthy controls. Genotyping was performed using sequence-specific PCR. Patients with AOSD were subdivided into groups according to disease course: monocyclic systemic, polycyclic systemic, or chronic articular type. Allelic, genotypic, and haplotypic associations were analyzed by chi-square test. Results. No significant skewing in any of the 3 FcγR polymorphisms was found between Korean AOSD patients and controls. FcγRIIA R/R131 and R/H131 genotype in patients with chronic articular-type disease was more frequent than in controls (p = 0.006 and pcorr = 0.018). No differences of genotypic and allelic frequencies were found between other disease course types and controls. Haplotype IIA R131-IIIA F176-IIIB NA2 was more frequent in AOSD patients than in controls (p = 0.021). Conclusion. Although FcγR polymorphisms are not associated with development of AOSD in Koreans, the haplotype IIA R131-IIIA F176-IIIB NA2 may be associated with AOSD. Also, the FcγRIIA polymorphism may be associated with chronic articular-type AOSD. We need to identify whether these polymorphisms are associated with a response to anti-tumor necrosis factor agents in patients with AOSD.

[1]  N. Kutukculer,et al.  Fc gamma RIIa, IIIa and IIIb polymorphisms in Turkish children susceptible to recurrent infectious diseases , 2006, Clinical and Experimental Medicine.

[2]  R. Deutsch,et al.  Fcγ receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor α–blocking agents , 2005 .

[3]  T. Hsieh,et al.  Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. , 2004, The Journal of rheumatology.

[4]  R. Geha,et al.  IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy. , 2003, The Journal of allergy and clinical immunology.

[5]  R. Wassmuth,et al.  Fcγ receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms , 2002, Annals of the rheumatic diseases.

[6]  C. Langefeld,et al.  Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[7]  C. Vedeler,et al.  Immunoglobulin G fc-receptor (FcgammaR) IIA, IIIA, and IIIB polymorphisms related to disease severity in rheumatoid arthritis. , 2002, The Journal of rheumatology.

[8]  S. Bae,et al.  Association Between FcgammaR IIa and IIIa polymorphism and clinical manifestations in Korean patients with adult-onset Still's disease. , 2002, Journal of Korean medical science.

[9]  K. Neftel,et al.  Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes , 2001, American journal of hematology.

[10]  L. van de Putte,et al.  Role of Fc receptor gamma chain in inflammation and cartilage damage during experimental antigen-induced arthritis. , 2000, Arthritis and rheumatism.

[11]  R. Kimberly,et al.  A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. , 1997, The Journal of clinical investigation.

[12]  M. Akizuki,et al.  Preliminary criteria for classification of adult Still's disease. , 1992, The Journal of rheumatology.

[13]  J. Esdaile,et al.  Adult Still's Disease: Manifestations, Disease Course, and Outcome in 62 Patients , 1991, Medicine.

[14]  R. Deutsch,et al.  Fcgamma receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor alpha-blocking agents. , 2005, Arthritis and rheumatism.

[15]  E. Thomas,et al.  Th1 and Th2 CD4 T Cells Provide Help for B Cell Clonal Expansion and Antibody Synthesis in a Similar Manner In Vivo , 2000 .

[16]  M. Newkirk,et al.  Aberrant cellular localization of rubella viral genome in patients with adult Still's disease--a pilot study. , 1993, Autoimmunity.